Pure Global
NCT06212531

Papuan Indigenous Model of Male Circumcision

The Papuan Indigenous Model of Voluntary Clinical Male Circumcision
University of Illinois at Chicago·ClinicalTrials.gov·procedureCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
HIV Infections
Drug/Device/Intervention
Medical male circumcision using standard surgical technique.
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
University of Illinois at Chicago
Location
Chicago, United States of America
Timeline & enrollment
Phase
N/A
Start date
Sep 07, 2020
End date
Aug 31, 2023
Enrollment
239 participants
Primary outcome

Proportion of male exposed to intervention who get circumcised.

Summary

The purpose of the study is: AIM 1: To engage Papuan community members to explore
 acceptability, barriers and facilitators for introducing a school-based age and culturally
 appropriate, comprehensive VMMC intervention to reduce HIV incidence in the Papuan
 population. AIM 2: To assess the capacity of the community health system to meet
 international criteria for safe comprehensive VMMC services and to ensure the availability of
 resources and training necessary to meet these criteria in selected clinics. AIM 3: To design
 the PIM of school-based adolescent VMMC based on information collected in Aims 1 and 2 and in
 consultation with a community advisory board, the Ministry of Health and the Ministry of
 Education. AIM 4: To pilot-test the school-based PIM Intervention of VMMC with 400 boys ages
 12-18 years at two HIV high-risk Papuan locations: the Nabire and Jayapura. Primary outcomes
 are the proportion of adolescent males exposed to school-based PIM VMMC educational and
 informational sessions who get circumcised and surgical event safety. Secondary outcomes are
 satisfaction by adolescent males and parents, any sexual activity within 6 weeks after
 circumcision, changes in sexual risk behaviors between base-line and 12 weeks after
 circumcision, and perceptions of providers regarding MC training and implementation, ease of
 device use, and challenges encountered.

ICD-10 classifications
HIV disease resulting in other viral infectionsHIV disease resulting in other bacterial infectionsHIV disease resulting in multiple infectionsAcute HIV infection syndromeHIV disease resulting in other infectious and parasitic diseases
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06212531
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06212531 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Illinois at Chicago and is currently Completed. The study focuses on HIV Infections. Target enrollment is 239 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.